Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is a cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its Dual Gene Therapy for curative and prevention therapies for diabetes and obesity. Its Nature Identical peptides for treatment of various ailments. Its BSV peptide program targets cancer progression. Its nonaddictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).


CSE:PREV - Post by User

Preveceutical Medical Inc
Bullboard Posts
User Avatar Image
(7)
•••
Post by TheCypheron Oct 11, 2018 6:55pm
120 Views
Post# 28784810

OCTOBER 16th 👀

OCTOBER 16th 👀Will be a pivotal day for us. Keep an eye on the short data, and ears to the ground re: PreveCeutical meeting in Montreal. 

www.eventbrite.ca/e/preveceutical-medical-inc-corporate-update-tickets-51099334485

https://shortdata.ca/stock/PREV.CN/

Short volume will be significantly higher than the October 1st 39.5 Million shares traded short. Some have suggested close to 90 Million. A QUARTER of the entire share float. Imaging what will happen when those shorts run for the hills. 

The meeting in Montreal will solidify details on the Penta5 acquisition, sealing revenue streams that compete with the largest players in the cannabis space, and that doesn’t begin to scratch the surface of income potential for PreveCeutical Medical. Stephen Van Deventer and his team will be one of the greats. History in the making. 

You heard it here. 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities